NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Xiaoqiang Wu
Florida State University - Tallahassee / United States
Others
AD Scientific Index ID: 5526025
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Xiaoqiang Wu's MOST POPULAR ARTICLES
1-)
A generalized framework of optimal two-stage designs for exploratory basket trialsX Wu, C Wu, F Liu, H Zhou, C ChenStatistics in Biopharmaceutical Research 13 (3), 286-294, 202192021
2-)
Optimal one-stage design and analysis for efficacy expansion in Phase I oncology trialsC Wu, F Liu, H Zhou, X Wu, C ChenClinical Trials 18 (6), 673-680, 202152021
3-)
Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial resultsJ Silverberg, E Guttman-Yassky, EL Simpson, KA Papp, A Blauvelt, ...BRITISH JOURNAL OF DERMATOLOGY 190, II8-II8, 202422024
4-)
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging studyT Passeron, K Ezzedine, I Hamzavi, N van Geel, BJ Schlosser, X Wu, ...EClinicalMedicine 73, 202412024
5-)
Developing large language models to detect adverse drug events in posts on xY Deng, Y Xing, J Quach, X Chen, X Wu, Y Zhang, C Moureaud, M Yu, ...Journal of Biopharmaceutical Statistics, 1-12, 20242024
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept